Novel Mechanisms of E2F Induction by BK Virus Large-T Antigen: Requirement of Both the PRb-binding and the J Domains
Overview
Affiliations
E2F activity is regulated in part by the retinoblastoma family of tumor suppressor proteins. Viral oncoproteins, such as simian virus 40 (SV40) large-T antigen (TAg), adenovirus E1A, and human papillomavirus E7, can disrupt the regulation of cellular proliferation by binding to pRb family members and dissociating E2F-pRb family protein complexes. BK virus (BKV), which infects a large percentage of the human population and has been associated with a variety of human tumors, encodes a TAg homologous to SV40 TAg. It has been shown that BKV TAg, when expressed at low levels, does not detectably bind to pRb family members, yet it induces a serum-independent phenotype and causes a decrease in the overall levels of pRb family proteins. The experiments presented in this report show that, despite the lack of TAg-pRb interactions, BKV TAg can induce transcriptionally active E2F and that this induction does in fact require an intact pRb-binding domain as well as an intact J domain. In addition, E2F-pRb family member complexes can be detected in both BKV and SV40 TAg-expressing cells. These results suggest the presence of alternate cellular mechanisms for the release of E2F in addition to the well-established model for TAg-pRb interactions. These results also emphasize a role for BKV TAg in the deregulation of cellular proliferation, which may ultimately contribute to neoplasia.
Weissbach F, Follonier O, Schmid S, Leuzinger K, Schmid M, Hirsch H J Virol. 2024; 98(12):e0138224.
PMID: 39513696 PMC: 11657676. DOI: 10.1128/jvi.01382-24.
Hsu Y, Chao C, Huang H, Zhao P, Hsu P, Shen C Virol J. 2023; 20(1):155.
PMID: 37464367 PMC: 10354968. DOI: 10.1186/s12985-023-02128-6.
Regulation of Virus Replication by BK Polyomavirus Small T Antigen.
Zou W, Imperiale M J Virol. 2023; 97(3):e0007723.
PMID: 36916919 PMC: 10062181. DOI: 10.1128/jvi.00077-23.
BK Polyomavirus Requires the Mismatch Repair Pathway for DNA Damage Response Activation.
Justice J, Needham J, Verhalen B, Jiang M, Thompson S J Virol. 2022; 96(8):e0202821.
PMID: 35389233 PMC: 9044952. DOI: 10.1128/jvi.02028-21.
Chiang R, Connor A, Inman B, Foo W, Howell D, Madden J Case Rep Urol. 2021; 2020:8881841.
PMID: 33425425 PMC: 7773455. DOI: 10.1155/2020/8881841.